BARDA announcement makes a new ballgame, especially if the company includes details of trial centers in the SS, when trials at each will start etc. Obviously he size of the grant would make a difference. Assume all cylinders are firing, you could see blue sky under the wings and where that leads is not going to come from chart analysis.
We’re talking serious market re-rating.
BARDA announcement makes a new ballgame, especially if the...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
-0.030(1.15%) |
Mkt cap ! $1.780B | |||
| Open | High | Low | Value | Volume |
| $2.61 | $2.63 | $2.57 | $1.570M | 605.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2918 | $2.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.60 | 1574 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |